US Patent Issued to Deepwell DTX on Jan. 13 for "Immersive medicine translational engine for development and repurposing of non-verified and validated code" (Canadian, American Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,525,344, issued on Jan. 13, was assigned to Deepwell DTX (Las Vegas).

"Immersive medicine translational engine for development and repurposing of non-verified and validated code" was invented by Ryan J. Douglas (Seattle), Matthew J. Douglas (Seattle), Parker J. Douglas (Victoria, Canada), Jalen S. Douglas (Victoria, Canada) and Michael S. Wilson (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Apparatus and associated methods relate to management of therapeutic digital assets in a non-medical environment. In an illustrative example, non-medical digital asset(s) (NMDAs) may be evaluated relative to one or more therapeutic modalities. A correspondi...